This is not the most recent version of the article. View current version (30 APR 2013)

Intervention Protocol

Phyllanthus species versus antiviral drugs for chronic hepatitis B virus infection

  1. Yun Xia1,*,
  2. Jian Ping Liu2,
  3. Christian Gluud3

Editorial Group: Cochrane Hepato-Biliary Group

Published Online: 16 FEB 2011

Assessed as up-to-date: 5 JAN 2011

DOI: 10.1002/14651858.CD009004


How to Cite

Xia Y, Liu JP, Gluud C. Phyllanthus species versus antiviral drugs for chronic hepatitis B virus infection (Protocol). Cochrane Database of Systematic Reviews 2011, Issue 2. Art. No.: CD009004. DOI: 10.1002/14651858.CD009004.

Author Information

  1. 1

    b) Cochrane Hepato-Biliary Group, Copenhagen Trial Unit, Centre for Clinical Intervention Research, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark, a) Centre for Evidence-Based Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China, Beijing, China

  2. 2

    b) National Research Centre in Complementary and Alternative Medicine (NAFKAM), Tromsø, Norway, c) Cochrane Hepato-Biliary Group, Copenhagen Trial Unit, Copenhagen, Denmark, a) Centre for Evidence-Based Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China, Beijing, China

  3. 3

    Copenhagen Trial Unit, Centre for Clinical Intervention Research, Department 3344, Rigshospitalet, Copenhagen University Hospital, Cochrane Hepato-Biliary Group, Copenhagen, Denmark

*Yun Xia, a) Centre for Evidence-Based Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China, b) Cochrane Hepato-Biliary Group, Copenhagen Trial Unit, Centre for Clinical Intervention Research, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark, 11 Bei San Huan Dong Lu, Chaoyang District, Beijing, 100029, China. xiayun_xy@126.com.

Publication History

  1. Publication Status: New
  2. Published Online: 16 FEB 2011

SEARCH

This is not the most recent version of the article. View current version (30 APR 2013)

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

The objective is to evaluate the benefits and harms of phyllanthus species for patients with chronic HBV infection.